Pyran[2,3-b] quinoline derivative as well as synthesis process and application thereof in tumor prevention

A synthetic process, 3-b technology, applied in the direction of antineoplastic drugs, drug combination, organic chemistry, etc., can solve the problem that synthetic raw materials are not easy to obtain, and achieve a good effect of inhibiting proliferation in vitro

Active Publication Date: 2018-06-29
JINGHUA PHARMA GRP NANTONG
View PDF7 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, some of these synthetic processes need to use noble metals as catalysts, and some synthetic raw materials are not easy to obtain

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pyran[2,3-b] quinoline derivative as well as synthesis process and application thereof in tumor prevention
  • Pyran[2,3-b] quinoline derivative as well as synthesis process and application thereof in tumor prevention
  • Pyran[2,3-b] quinoline derivative as well as synthesis process and application thereof in tumor prevention

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0033] Add 2-chloroquinoline-3-carbaldehyde (0.2mmol), malononitrile (0.2mmol) and 4-hydroxycoumarin (0.2mmol) into a 5mL microwave reaction tube, then add L-proline (0.1mmol ) and 2 mL of ethanol, seal the reaction tube, stir for 10 seconds in advance, and react the mixture at 100°C for 30 minutes under microwave radiation. A mixed solvent of water was recrystallized to obtain 2-(6-oxo-6,7-dihydrochromeno[3',4':5,6]pyrano[2,3-b]quinoline-7 -yl) malononitrile (Ia): Yield 71%; m.p.:274-276°C; IR(KBr,ν,cm -1 ):2917,2250,1701,1638,1607,1493,1404,1332,1244,1204,1169,1151,1050,1025,987,769,754; 1 H NMR (400MHz, DMSO-d 6 )(δ,ppm):8.84(s,1H,ArH),8.15(d,J=8.0Hz,2H,ArH),8.04(d,J=8.4Hz,1H,ArH),7.94-7.90(m, 1H, ArH), 7.86-7.82(m, 1H, ArH), 7.70(t, J=7.6Hz, 1H, ArH), 7.61(d, J=8.4Hz, 1H, ArH), 7.57(t, J= 8.0Hz, 1H, ArH), 5.38(d, J=4.0Hz, 1H, CH), 5.34(d, J=3.6Hz, 1H, CH). 13 C NMR (100MHz, DMSO-d 6 )(δ,ppm):162.3,160.0,158.5,153.7,152.6,145.6,140.8,134.0,131.9,128.3,127.6,127.0,12...

Embodiment 2

[0035] According to the method for embodiment 1, 2-chloroquinoline-3-formaldehyde is changed into 6-methoxyl group-2-chloroquinoline-3-formaldehyde, with L-proline as catalyst, reacted under microwave radiation for 30 minutes, After the reaction, the reaction system was cooled to room temperature, and after the solid was precipitated, suction filtration was performed, and the target product 2-(10-methoxy-6-oxo-6,7-di Hydrochromeno[3',4':5,6]pyrano[2,3-b]quinolin-7-yl)malononitrile (Ib): Yield 75%; m.p.:258-260°C; IR(KBr,ν,cm -1 ):2903,2254,1686,1637,1609,1497,1455,1353,1236,1172,1113,1025,1005,993,794,747; 1 H NMR (400MHz, DMSO-d 6 )(δ,ppm):8.69(s,1H,ArH),8.14-8.11(m,1H,ArH),7.94(d,J=9.2Hz,1H,ArH),7.85-7.81(m,1H,ArH ),7.61-7.53(m,4H,ArH),5.35(d,J=3.6Hz,1H,CH),5.31(d,J=3.6Hz,1H,CH),3.94(s,3H,CH 3 O). 13 C NMR (75MHz, DMSO-d 6 )(δ,ppm):160.5,159.0,158.1,153.1,152.6,141.7,139.6,134.4,129.5,128.6,125.7,124.9,123.4,117.4,113.7,113.6,113.2,112.9,106.4,67.7 , 30.8. HRMS Calcd...

Embodiment 3

[0037] According to the method for Example 1, 2-chloroquinoline-3-formaldehyde is replaced with 6-tert-butyl-2-chloroquinoline-3-formaldehyde, and L-proline is used as a catalyst to react under microwave radiation for 30 minutes, After the reaction, the reaction system was cooled to room temperature, and after the solid was precipitated, suction filtration was performed, and the target product 2-(10-tert-butyl-6-oxo-6,7-di Hydrochromeno[3',4':5,6]pyrano[2,3-b]quinolin-7-yl)malononitrile (Ic): Yield 73%; m.p.: 284-286°C; IR(KBr, ν, cm -1 ):2963,2255,1702,1640,1610,1497,1460,1438,1396,1380,1366,1271,1183,1169,1150,1126,1098,988,969,915,831; 1 H NMR (400MHz, DMSO-d 6 )(δ,ppm):8.82(s,1H,ArH),8.17(d,J=7.6Hz,1H,ArH),8.09-8.00(m,3H,ArH),7.86(t,J=8.0Hz, 1H, ArH), 7.64-7.58(m, 2H, ArH), 5.38(d, J=3.6Hz, 1H, CH), 5.34(d, J=3.6Hz, 1H, CH), 1.45(s, 9H, (CH 3 ) 3 C). 13 C NMR (75MHz, DMSO-d 6 )(δ,ppm):160.5,158.9,153.9,153.1,150.0,144.5,141.1,134.5,131.4,127.7,127.1,125.7,123.4,11...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a pyran[2,3-b] quinoline derivative as well as a synthesis process and application thereof in tumor prevention. According to the synthesis process, multiple components are adopted to react, namely, a compound of chemical formula II, malononitrile and 4-hydroxycoumarin as raw materials, are subjected to three-component reactions in the presence of a solvent under catalysisof a solvent and the microwave radiation, then a target compound is synthesized at one step, that is, the pyran[2,3-b] quinoline derivative (formula I). The pyran[2,3-b] quinoline derivative has the advantages that multi-component reactions are carried out in the synthesis process, the pyran[2,3-b] quinoline derivative is synthesized from the three raw materials by using a 'one pot boiling' method, the derivative is a quite stable compound, and the compound has a relatively good in-vitro propagation inhibition function on a human liver tumor cell system HepG2.

Description

technical field [0001] The invention belongs to the technical field of organic synthesis, and in particular relates to pyrano[2,3-b]quinoline derivatives, their synthesis process and their anti-tumor application. Background technique [0002] Pyran is an important class of heterocyclic compounds, and its derivatives have a wide range of biological and pharmacological activities, such as antiallergic effects (Witte, E.C.; Neubert, P.; Roesoh, A.DE 3427985, 1986), hypoglycemic effects (Jiang Hong, Wang Lijun, Zhao Zhixue, Journal of Beihua University (Natural Science Edition), 2001, 2, 489), anticancer activity (Hyama, T.; Saimoto, H.JP62181271, 1987), can be used to treat allergic tracheitis ( Chand, N.; Diamantis, W.; Sofia, R.D.Br.J.Pharmacol., 1986, 87, 443), anti-dysplasia (Brooks, G.T.; Ottridge, A.P.; Maee, D.W.Pestic. SCi., 1988, 22, 41 ) and treatment of diabetes (Suarez, M.; Ochoa, E.; Verdecia, Y.; Martin, M.; Quinteiro, C.; Seoane, J.; Soto, J.L.; Novoa, N.; Blato...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07D491/153A61P35/00
CPCC07D491/153
Inventor 吴玉祥严宾朱春林
Owner JINGHUA PHARMA GRP NANTONG
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap